Lost in Translation: Improving Genomic Test Reporting to Boost Precision Oncology

Lost in Translation: Improving Genomic Test Reporting to Boost Precision Oncology

With the advent of next-generation sequencing (NGS) technologies just over a decade ago, genomic information became available not only in labs, but also in clinical practice. Today, genomic testing is starting to play an important role in cancer patient care. Knowing the genetic makeup of a tumor can help oncologists determine the best therapeutic options for a patient, making genomic testing a growing part of precision medicine. Benedikt Westph…

Genomia MDATA and the Mohammed VI Foundation for Science and Health (FM6SS): a strategic alliance to transform precision medicine in Africa – A technological and collaborative hub for medical innovation Genomia MDATA, the international leader in precision medicine of Canadian origin, and the Mohammed VI Foundation for Science and ... This article Genomia MDATA and the Mohammed VI Foundation for Science and Health: an alliance for the benefit of …

The genomic platform will be an integral tool that not only allows advanced analysis of genetic data, but also facilitates the interpretation of results and supports in the making of personalized therapeutic decisions